Cargando…
Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer
Combinatorial therapies that target multiple signaling pathways may provide improved therapeutic responses over monotherapies. Celecoxib and curcumol are two highly hydrophobic drugs which show bioavailability problems due to their poor aqueous solubility. In the present study, we evaluated the effe...
Autores principales: | Cai, Fangfang, Chen, Minghui, Zha, Daolong, Zhang, Peng, Zhang, Xiangyu, Cao, Nini, Wang, Jishuang, He, Yan, Fan, Xinxin, Zhang, Wenjing, Fu, Zhongping, Lai, Yueyang, Hua, Zi-Chun, Zhuang, Hongqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777791/ https://www.ncbi.nlm.nih.gov/pubmed/29383179 http://dx.doi.org/10.18632/oncotarget.23308 |
Ejemplares similares
-
Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
por: Cao, Nini, et al.
Publicado: (2020) -
Aspirin potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer by targeting GRP78 activity
por: Zhang, Xiangyu, et al.
Publicado: (2020) -
Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner
por: Chen, Minghui, et al.
Publicado: (2016) -
Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-κB pathway
por: Chen, Minghui, et al.
Publicado: (2017) -
ADT-OH, a hydrogen sulfide-releasing donor, induces apoptosis and inhibits the development of melanoma in vivo by upregulating FADD
por: Cai, Fangfang, et al.
Publicado: (2020)